There are couple of issues with the paper. 1. effect on young patients have not been analyzed. 2. The participants received exceptional medical care and therefore there was no difference between control and experimental group in terms of mortality. 3. Protection is partial unlike other vaccines. 4. It is not clear why did they publish the partial results. The associated editorial in the issue by Nicholas J. White is thought-provoking.